Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.78
  • Today's Change-0.02 / -1.11%
  • Shares traded176.26k
  • 1 Year change-27.64%
  • Beta2.1374
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of May 31 2024202420232022
OPERATIONS
Net income(222)(1443)(434)
Depreciation/depletion127130155
Non-Cash items1121,338222
Cash taxes paid, supplemental----0
Cash interest paid, supplemental------
Changes in working capital(8.87)14(92)
Total cash from operations(31)7.91(177)
INVESTING
Capital expenditures(29)(21)(34)
Other investing and cash flow items, total158(264)13
Total cash from investing128(285)(22)
FINANCING
Financing cash flow items00(7.48)
Total cash dividends paid------
Issuance (retirement) of stock, net8.62128259
Issuance (retirement) of debt, net(84)(58)(124)
Total cash from financing(75)70128
NET CHANGE IN CASH
Foreign exchange effects(0.55)(2.23)(1.96)
Net change in cash22(209)(73)
Net cash-begin balance/reserved for future use207416488
Net cash-end balance/reserved for future use228207416
SUPPLEMENTAL INCOME
Depreciation, supplemental127130155
Cash interest paid, supplemental------
Cash taxes paid, supplemental----0
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.